ROETTO, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 3819
EU - Europa 2517
AS - Asia 1278
OC - Oceania 21
AF - Africa 13
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7657
Nazione #
US - Stati Uniti d'America 3787
CN - Cina 831
IE - Irlanda 404
IT - Italia 361
SE - Svezia 313
FR - Francia 268
FI - Finlandia 251
DK - Danimarca 240
UA - Ucraina 216
KR - Corea 182
DE - Germania 148
VN - Vietnam 95
PL - Polonia 70
JP - Giappone 68
BE - Belgio 51
GB - Regno Unito 51
AT - Austria 43
IN - India 37
NL - Olanda 35
CA - Canada 28
AU - Australia 21
TW - Taiwan 14
TR - Turchia 13
ES - Italia 11
HK - Hong Kong 11
PT - Portogallo 11
RO - Romania 10
CH - Svizzera 8
RU - Federazione Russa 8
ET - Etiopia 7
GR - Grecia 6
ID - Indonesia 5
MY - Malesia 5
EU - Europa 4
LB - Libano 3
LK - Sri Lanka 3
MX - Messico 3
SN - Senegal 3
BG - Bulgaria 2
BR - Brasile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
IR - Iran 2
NO - Norvegia 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BZ - Belize 1
CL - Cile 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
SG - Singapore 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 7657
Città #
Chandler 709
Beijing 496
Ann Arbor 445
Dublin 403
Fairfield 252
Houston 234
Villeurbanne 215
Wilmington 166
Ashburn 129
Princeton 128
Medford 125
Seattle 123
Jacksonville 121
Woodbridge 120
Dearborn 116
Torino 102
Cambridge 100
Pisa 82
Nyköping 74
Warsaw 69
Redwood City 63
Boardman 59
Boston 56
Dong Ket 56
Shanghai 44
Vienna 42
Fremont 37
Brussels 35
Nanjing 33
Düsseldorf 25
San Diego 23
Wuhan 23
Turin 20
San Mateo 19
Hangzhou 18
Shenyang 17
Norwalk 15
Chengdu 13
Milan 13
Phoenix 13
Waanrode 13
Guangzhou 12
Nanchang 12
Taipei 12
Changsha 11
Dresden 11
Hefei 11
Jinan 11
Toronto 11
Des Moines 10
Nijmegen 10
Silver Spring 10
Zhengzhou 10
Falls Church 9
Hebei 9
Chennai 8
Hanover 8
Munich 8
Asciano 7
Buffalo 7
Tokyo 7
Detroit 6
Heidelberg 6
Kunming 6
Tianjin 6
Xian 6
Brisbane 5
Chongqing 5
Gloucester 5
Montréal 5
Napoli 5
Paris 5
Seoul 5
Berlin 4
Eschweiler 4
Harbin 4
Hyderabad 4
London 4
Manitowoc 4
Modena 4
New York 4
Ottawa 4
Baotou 3
Bethesda 3
Central District 3
Chicago 3
Duncan 3
Grafing 3
Iasi 3
Kolkata 3
Montpellier 3
Mountain View 3
Muenster 3
Padova 3
Perugia 3
Rock Hill 3
Saint Louis 3
Southend 3
Vestignè 3
Washington 3
Totale 5195
Nome #
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 517
Comparison of 3 Tfr2-deficient murine models suggestsdistinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues 323
A comparative study of myocardial molecular phenotypes of two tfr2β null mice: Role in ischemia/reperfusion 253
Two novel mutations in the tmprss6 gene associated with iron-refractory iron-deficiency anaemia (irida) and partial expression in the heterozygous form 216
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 194
Hemochromatosis due to mutations in transferrin receptor 2. 191
Analysis of microsatellite instability in chronic lymphoproliferative disorders 172
A child with hyperferritinemia: case report 170
Screening hepcidin for mutations in juvenile hemochromatosis: identification of a new mutation (C70R). 162
Rare Genetic Anemias Due to Defective Iron Recycling: Aceruloplasminemia and Type 4 Hemochromatosis 159
Development of cellular and humoral response against WT1 protein vaccination in mice 156
Altered Erythropoiesis in Mouse Models of Type 3 Hemochromatosis 154
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse 147
The ancestral hemochromatosis haplotype is associated with a severe phenotype expression in Italian patients 146
Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. 145
Allelic association of microsatellites of 6p in Italian hemochromatosis patients 132
The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice 124
Characterization of human mitochondrial ferritin promoter: Identification of transcription factors and evidences of epigenetic control 121
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors 113
Construction of a YAC contig covering human chromosome 6p22 97
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 93
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signalling 90
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 88
COMPORTAMENTO ANSIOSO NEI TOPI TFR2 KO: NUOVO COLLEGAMENTO TRA SOVRACCARICO CEREBRALE DI FERRO E ANSIA NELLE MALATTIE NEURODEGENERATIVE? 80
Altered erythropoiesis in mouse models of type 3 Hemochromatosis (Hh3) 79
A recombination event close to HFE gene in hereditary hemochromatosis 76
THE PHENOTYPE OF TFR2-TMPRSS6 DOUBLE KNOCK OUT MICE ONLY PARTIALLY OVERLAPS THAT OF TMPRSS6 NULL MICE 76
Identification of New BMP6 Pro-Peptide Mutations in Patients with Unexplained Iron-Overload 74
A valine deletion of ferroportin 1: a common mutation in hemochromastosis type 4 70
A pilot C282Y hemochromatosis screening in Italian newborns by TaqMan technology. 70
ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA 69
Feasibility of molecular diagnosis of alpha-thalassemia in the evaluation of microcytosis 67
Identification of a Novel Mutation in the L Ferritin Iron-Responsive Element Causing Hereditary Hyperferritinemia-Cataract Syndrome 64
Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing 62
The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value 62
Anemia and iron overload due to genetic defects of iron recycling, aceruloplasminemia and hemochromatosis type 4 61
Construction of a genetic map telomeric to HAL-A by microsatellite analysis 60
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia - response to Jasperset al 60
Detection of humoral immune responses against WT1 antigenin patients affected by different hematological malignancies 56
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron. 54
New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. 53
Patologie da sovraccarico di ferro 53
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 50
Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes 49
Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. 48
Heterogeneity of hemochromatosis in Italy 48
Comparison of clinical expression of type 2 (juvenile) and type 3 hemochromatosis. RID B-1183-2008 47
null 47
Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis 47
Deferasirox is a powerful NF-kappaB inhibitor inmyelodysplastic cells and in leukemia cell lines acting independently from celliron deprivation by chelation and reactive oxygen species scavenging 46
The Molecular Spectrum of β- and α-Thalassemia Mutations in Non-Endemic Umbria, Central Italy 46
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. 45
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. 45
Mutations in transferrin receptor-2 in hemochromatosis type 3. 44
New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. 44
A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. 44
Juvenile and adult hemochromatosis are distinct genetic disorders 44
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation 43
New polymorphisms and markers in the HLA class I region: relevance to hereditary hemochromatosis (HFE) 43
Commentary: Juvenile hemochromatosis in a Spanish family (by Montes-Cano et al.). 42
null 42
Hereditary hemochromatosis: Generation of a transcription map within a refined and extended map of the HLA class I region 42
The natural history of hemochromatosis type 2. 42
Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver 42
Genetic haemochromatosis: genes and mutations associated with iron loading. 41
Juvenile hemochromatosis locus maps to chromosome 1q. 41
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. 41
Iron: An Essential Element of Cancer Metabolism 41
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 41
BBB damage in aging causes brain iron deposits via astrocyte-neuron crosstalk and Hepc/Fpn1 pathway activation 41
Two polymorphic repeats in the candidate region for the haemochromatosis gene 40
Identification of new BMP6 pro-peptide mutations in patients with iron overload 40
Molecular and clinical studies in hemochromatosis type 2 and 3 40
Deferasiroxtreatment improved the hemoglobin level and decreased transfusion requirements infour patients with the myelodysplastic syndrome and primary myelofibrosis 39
Brain iron deposits during aging: activation of the Hepc/Fpn1 pathway. 39
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. 38
Fisiopatologia Molecolare del Matbolismo del ferro 38
Non-HFE hemochromatosis: insights into regulation on iron metabolisms from novel iron loading disorders. 38
Cloning of a new gene (FB19) within HLA class I region 38
HETEROZYGOUS β-THALASSEMIA AND HOMOZYGOUS H63D HEMOCHROMATOSIS IN A CHILD: A 16-YEAR FOLLOW-UP 37
Hereditary Hemochromatosis 37
Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study 37
Hereditary hemochromatosis: progress and perspectives 36
Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. 36
Linkage analysis of 6p21 polymorphic markers and the hereditary hemochromatosis: localization of the gene centromeric to HLA-F 36
null 35
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients 35
Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient. 34
Modulazione genetica e ambientale del fenotipo nelle malattie genetiche 34
Exclusion of ZIRTL as candidate gene of juvenile hemochromatosis and refinement of the critical interval on 1q21. 33
Hepcidin is decreased in TFR2 hemochromatosis. 33
Heterozygous beta-thalassemia and homozygous H63D hemochromatosis in a child: an 18-year follow-up. 32
Juvenile hemochromatosis. 32
Molecular defects in two genetic disorders of iron recycling: aceruloplasminemia and hemochromatosis type 4 32
Hereditary hemochromatosis: a HpaI polymorphism within the HLA-H gene 32
Different hematological phenotypes caused by the interaction of triplicated alpha-globin genes and heterozygous beta-thalassemia 32
Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload 32
Linkage to chromosome 1q in Greek families with juvenile hemochromatosis. 31
Juvenile hemochromatosis locus maps to chromosome 1q in a French Canadian population. 31
TFR2 BETA ISOFORM HAS A ROLE IN CARDIAC IRON METABOLISM 31
Totale 7503
Categoria #
all - tutte 12759
article - articoli 0
book - libri 0
conference - conferenze 2367
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018696 0000 00 0133 423124610
2018/2019610 1743147 2517 1776 288118780
2019/20201446 515671168 92243 155139 1391409894
2020/20211131 96498160 13878 11148 1427681171
2021/20221518 755353129 7169 118102 81148338281
2022/20231543 22416261224 203511 1580 0000
Totale 8035